Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma

BACKGROUND: Once-daily, single-inhaler mometasone furoate/indacaterol acetate/glycopyrronium bromide (MF/IND/GLY, an ICS/LABA/LAMA) and MF/IND (an ICS/LABA) via Breezhaler(®) have been approved for the maintenance treatment of patients with asthma inadequately controlled with medium-or high-dose ICS...

Descripción completa

Detalles Bibliográficos
Autores principales: van Zyl-Smit, Richard N, Chapman, Kenneth R, Kerstjens, Huib A M, Gessner, Christian, Sagara, Hironori, Tanase, Ana-Maria, Hosoe, Motoi, Pethe, Abhijit, Lawrence, David, Tillmann, Hanns-Christian, D’Andrea, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880009/
https://www.ncbi.nlm.nih.gov/pubmed/36714049
http://dx.doi.org/10.2147/JAA.S392975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880009/
https://www.ncbi.nlm.nih.gov/pubmed/36714049
http://dx.doi.org/10.2147/JAA.S392975

Ejemplares similares